N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction

European Journal of Heart Failure

Volumn 6, Issue 3, 2004, Pages 301-308

  Bayés Genís, Antoni ^a,b   Santaló Bel, Miquel ^a   Zapico Muñiz, Edgar ^a   López, Laura ^a   Cotes, Carlos ^a   Bellido, Jesús ^a   Leta, Rubén ^a   Casan, Pere ^a   Ordóñez Llanos, Jordi ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Dyspnoea; N terminal probrain natriuretic peptide; Ventricular dysfunction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DYSPNEA; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; EMERGENCY WARD; EVALUATION; FEMALE; HEART FAILURE; HEART VENTRICLE FUNCTION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; REDUCTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DYSPNEA; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TROPONIN T; VENTRICULAR DYSFUNCTION;

EID: 1342291268     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2003.12.013     Document Type: Article

References (31)

1. Heart disease and stroke statistics - 2003 update. American Heart Association, Dallas, TX 2002.
2. Ho K.K.L., Anderson K.M., Kannel W.B., Grossman W., Levy D. Survival after onset of congestive heart failure in Framingham heart study subjects. Circulation. 88:1993;107-115.
3. Hobbs F.D., Kenkre J.E., Roalfe A.K., Davis R.C., Hare R., Davies M.K. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J. 23:2002;1867-1876.
4. Rich M.W., Nease R.F. Cost-effectiveness analysis in clinical practice. The case of heart failure. Arch Intern Med. 159:1999;1690-1700.
5. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. J Am Coll Cardiol. 38:2001;2101-2113.
6. Heart failure evaluation and care of patients with left ventricular systolic dysfunction. 1994;Agency for Health Care Policy and Research, Rockville, MD.
7. Hobbs F.D., Jones M.I., Allan T.F., Wilson S., Tobias R. European survey of primary care physicians perceptions on heart failure diagnosis and management (Euro-HF). Eur Heart J. 21:2000;1877-1887.
8. Sagnella G. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci. 95:1998;519-529.
9. Levin E.R., Gardner D.G., Samson W.K. Natriuretic peptides. N Engl J Med. 339:1998;321-328.
10. Maisel A.S., Koon J., Krishnaswamy P., et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 141:2001;367-374.
11. Hammerer-Lercher A., Neubauer E., Muller S., Pachinger O., Puschendorf B., Mair J. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta. 310:2001;193-197.
12. Masson S., Vago T., Baldi G., et al. Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure. Clin Chem Lab Med. 40:2002;761-763.
13. Maisel A.S., Krishnaswami P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 347:2002;161-167.
14. Ommen S.R., Nishimura R.A., Appleton C.P., et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler- catheterization study. Circulation. 102:2000;1788-1794.
15. Wuerz R.C., Meador S.A. Effects of prehospital medications on mortality and length of stay in congestive heart failure. Ann Emerg Med. 21:1992;669-674.
16. Morrison L.K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnoea. J Am Coll Cardiol. 39:2002;202-209.
17. McCullough P.A., Nowak R.M., McCord J., et al. B-type netriuretic peptide and clinical judgement in emergency diagnosis of heart failure: analysis from breathing not properly (BNP) multinational study. Circulation. 106:2002;416-422.
18. Richards A.M., Nicholls M.G., Yandle T.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin. New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 97:1998;1921-1929.
19. Stanek B., Frey B., Hulsamm M., et al. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol. 38:2001;436-442.
20. Lainchbury J.G., Campbell E., Frampton C.M., Yandle T.G., Nicholls M.G., Richards A.M. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol. 42:2003;728-735.
21. James S.K., Lindahl B., Siegbahn A., et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. A global utilization of strategies to open occluded arteries (GUSTO)-IV substudy. Circulation. 108:2003;275-281.
22. Kinnunen P., Vuolteenaho O., Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology. 132:1993;1961-1970.
23. Magga J., Vuolteenaho O., Tokola H., Marttila M., Ruskoaho H. B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression. Ann Med. 30:(Suppl 1):1998;39-45.
24. Richards A.M., Crozier I.G., Yandle T.G., Espiner E.A., Ikram H., Nicholls M.G. Brain natriuretic factor: regional plasma concentrations and correlations with hemodynamic state in cardiac disease. Br Heart J. 69:1993;414-417.
25. Talwar S., Squire I.B., Downie P.F., et al. Profile of plasma N-terminal proBNP following acute myocardial infarction. Correlation with left ventricular systolic dysfunction. Eur Heart J. 21:2000;1514-1521.
26. Osca J., Quesada A., Arnau M.A., et al. Péptido cerebral natriurético. Valor diagnóstico en la insuficiencia cardiaca. Rev Esp Cardiol. 55:2002;7-15.
27. Troughton R.W., Frampton C.M., Yandle T.G., Espiner E.A., Nicholls M.G., Richards A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 355:2000;1126-1130.
28. Troughton R.W., Frampton C.M., Yandle T.G., Espiner E.A., Nicholls M.G., Richards A.M. Plasma amino-terminal B-type natriuretic peptide measured by Elecsys 2010 assay in a trial of hormone-guided treatment for heart failure. Clin Chem. 49:2003;1212-1215.
29. Burger A., Burger M. BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential. Curr Invest Drugs. 2:2001;929-935.
30. De Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 345:2001;1014-1021.
31. Jernberg T., Stridsberg M., Venge P., Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST segment elevation. J Am Coll Cardiol. 40:2002;437-445.